Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiepi Fengdou Jing is a Traditional Chinese Medicine (TCM) health supplement developed and manufactured by Hangzhou Huqingyutang Pharmaceutical. It is formulated as oral granules containing extracts of *Dendrobium officinale* (Tiepi Shihu) and American ginseng (*Panax quinquefolius*), along with glucose. The product is registered as a health food in China (approval number: 国食健字G20040171) and is indicated for immune regulation and the relief of physical fatigue. It is intended for adults with low immunity or those who are easily fatigued. As a TCM-based supplement, its effects are attributed to the presence of crude polysaccharides and ginsenosides (specifically Rb1), which are thought to support general wellness and stamina. The product labeling explicitly states that it is a health supplement and cannot replace medication for treating diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tiepi Fengdou Jing.